Pacific Biosciences of California sets $300 price point for 20x human genome sequencing on Revio

Pacific Biosciences of California sets $300 price point for 20x human genome sequencing on Revio
Pacific Biosciences sets $300 sequencing

Pacific Biosciences of California has announced that HiFi long-read sequencing of a 20x human genome on its Revio platform costs approximately $300 per sample.

This move aims to make premium PacBio accuracy more accessible to laboratories working within tighter budgets. The company provided a detailed breakdown showing that the $300 price applies to sequencing runs using SPRQ-Nx, targeting researchers looking to balance cost-effectiveness with high-quality genomics data. Labs are encouraged to review the full cost analysis in Pacific Biosciences of California's latest informational release.

Pacific Biosciences of California previously highlighted its HiFi sequencing for achieving 99.9 percent accuracy with no GC bias compared to Nanopore-based techniques, according to a recent overview. The company has also hosted a PacBioPRISM event in Fukuoka to connect global researchers, combining scientific presentations and cultural activities, as reported in an earlier update. These initiatives continue as PacBio works to expand access and engagement around its sequencing platforms.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.